This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Heinrich-Pette-Institut Für Experimentelle Virologie Und Immunologie an Der Universität Hamburg, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Technische Universitát Dresden. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 1,335 
1 out of 100 
Years Active: 2014
Title: Indrani Sarkar: Innovator in Retroviral Treatment
Introduction
Indrani Sarkar is a notable inventor based in Kolkata, India. She has made significant contributions to the field of biotechnology, particularly in the treatment of retroviral infections. Her innovative approach has the potential to change the landscape of how such infections are managed.
Latest Patents
Indrani Sarkar holds a patent for the "Use of tailored recombinases for the treatment of retroviral infections." This invention focuses on a method for preparing an expression vector that encodes a tailored recombinase. The tailored recombinase is designed to recombine asymmetric target sites within the long terminal repeat (LTR) of proviral DNA of a retrovirus. This method is instrumental in excising the provirus from the genome of a host cell. Furthermore, her invention includes an in vitro method for optimizing the treatment of retroviral infections and the use of tailored recombinases in pharmaceutical compositions aimed at reducing viral load in infected subjects. She has 1 patent to her name.
Career Highlights
Indrani has worked with prestigious institutions such as Technische Universität Dresden and the Max Planck Society for the Advancement of Science. Her work in these organizations has allowed her to collaborate with leading experts in the field, enhancing her research and innovation capabilities.
Collaborations
Some of her notable coworkers include Joachim Hauber and Frank Buchholz. Their collaboration has contributed to the advancement of research in retroviral treatments.
Conclusion
Indrani Sarkar's innovative work in the field of retroviral treatment showcases her dedication to advancing medical science. Her patented methods have the potential to significantly impact the treatment of retroviral infections, making her a key figure in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile